BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang YH, Bae SI, Kim WH. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. J Cancer Res Clin Oncol. 2002;128:119-124. [PMID: 11935297 DOI: 10.1007/s00432-001-0296-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wielandt AM, Hurtado C, Moreno C M, Villarroel C, Castro M, Estay M, Simian D, Martinez M, Vial MT, Kronberg U, López-Köstner F. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Tumour Biol 2020;42:1010428320938492. [PMID: 32635826 DOI: 10.1177/1010428320938492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
2 Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, Ahuja YR, Hasan Q. Dna Methylation in Esophageal Diseases Including Cancer: Special Reference to hMLH1 Gene Promoter Status. Tumori 2006;92:155-62. [DOI: 10.1177/030089160609200212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
3 Hu S, Kong X, Cheng Z, Sun Y, Shen G, Xu W, Wu L, Xu X, Jiang X, Huang D. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori 2010;96:726-33. [DOI: 10.1177/030089161009600515] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
4 Moghbeli M, Moaven O, Memar B, Raziei HR, Aarabi A, Dadkhah E, Forghanifard MM, Manzari F, Abbaszadegan MR. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J Gastrointest Cancer. 2014;45:40-47. [PMID: 24022108 DOI: 10.1007/s12029-013-9548-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
5 Choe WH, Lee SY, Lee JH, Shim SG, Kim YH, Rhee PL, Rhee JC, Ki CS, Kim JW, Song SY, Kim JJ. High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients. Korean J Intern Med 2005;20:116-22. [PMID: 16134765 DOI: 10.3904/kjim.2005.20.2.116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
6 Hudler P, Vouk K, Liovic M, Repse S, Juvan R, Komel R. Mutations in the hMLH1 gene in Slovenian patients with gastric carcinoma. Clin Genet. 2004;65:405-411. [PMID: 15099349 DOI: 10.1111/j.0009-9163.2004.0234.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
7 Park JK, Lee SH, Kang JH, Nishio K, Saijo N, Kuh HJ. Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells. Anticancer Drugs. 2004;15:809-818. [PMID: 15494644 DOI: 10.1097/00001813-200409000-00011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
8 Baker K, Zhang Y, Jin C, Jass JR. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 2004;57:1089-93. [PMID: 15452166 DOI: 10.1136/jcp.2004.016600] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
9 Yao Y, Tao H, Kim JJ, Burkhead B, Carloni E, Gasbarrini A, Sepulveda AR. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines. Lab Invest. 2004;84:915-922. [PMID: 15133479 DOI: 10.1038/labinvest.3700117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
10 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(6): 1384-1388 [DOI: 10.11569/wcjd.v12.i6.1384] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Zhao CH, Liu HX, Bu XM. Mutation of mismatch repair gene hMLH3 in familial gastric cancer. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1030-1033 [DOI: 10.11569/wcjd.v12.i5.1030] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Johnson DH. Targeted therapy in non-small cell lung cancer: myth or reality. Lung Cancer 2003;41:3-8. [DOI: 10.1016/s0169-5002(03)00133-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
13 Kang GH, Lee S, Shim YH, Kim JC, Ro JY. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Pathol Int 2002;52:764-8. [PMID: 12588445 DOI: 10.1046/j.1440-1827.2002.01423.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
14 Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol 2003; 9(1): 26-29 [PMID: 12508345 DOI: 10.3748/wjg.v9.i1.26] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]